CSIMarket
 


Rocket Pharmaceuticals Inc   (RCKT)
Other Ticker:  
 

Cumulative Rocket Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

RCKT's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

RCKT Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth 47.31 % 3.94 % 9.88 % 7.69 % -24.37 %
Y / Y Total Liabilities Growth 15.46 % 33.19 % 31.39 % 46.87 % 12.04 %
Leverage Ratio for Trailing Twelve Months Period 0.12 0.13 0.12 0.12 0.11
Total Ranking # 217 # 272 # 280 # 312 # 296
Seq. Equity Growth 34.27 % -12.18 % -6.29 % 33.32 % -5.26 %
Seq. Total Liabilities Growth -1.93 % 5.24 % -10.04 % 24.36 % 13.13 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to debt repayement of -1.93% Rocket Pharmaceuticals Inc decreased Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 0.12, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 72 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Rocket Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are RCKT's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 73
Sector # 104
S&P 500 # 179


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.98 0.31 0.09
(Dec 31 2017)   (Mar 31 2022)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Evotec Se  0.34 
Benitec Biopharma Inc   0.33 
Regulus Therapeutics Inc   0.33 
Genelux Corporation  0.33 
Bolt Biotherapeutics Inc   0.33 
Universe Pharmaceuticals Inc  0.32 
Longeveron Inc   0.32 
Neximmune Inc   0.32 
Praxis Precision Medicines Inc   0.31 
Vincerx Pharma Inc   0.31 
Hcw Biologics Inc   0.31 
Avricore Health Inc   0.31 
Nkarta Inc   0.31 
Vertex Pharmaceuticals Inc  0.31 
23andme Holding Co  0.30 
Bionomics Limited  0.30 
Stoke Therapeutics Inc   0.30 
Y mabs Therapeutics inc   0.30 
Aclaris Therapeutics Inc   0.29 
Pharming Group N v   0.29 
Dermata Therapeutics Inc   0.29 
Savara Inc   0.29 
Schrodinger Inc   0.28 
Concert Pharmaceuticals Inc   0.28 
Puretech Health Plc  0.28 
Virpax Pharmaceuticals Inc   0.28 
Biohaven Ltd   0.28 
Chinook Therapeutics Inc   0.28 
Repare Therapeutics Inc   0.28 
Ampio Pharmaceuticals inc   0.27 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com